Disease Info Card

Gerstmann-straussler-scheinker Disease

Information about Gerstmann-straussler-scheinker Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Gerstmann-straussler-scheinker Disease

Most recent studies have shown that Gerstmann-straussler-scheinker Disease shares some biological mechanisms with alzheimers-disease, amyloidosis, ataxia, atrophy, creutzfeldt-jakob-disease, dementia, dental-plaque, encephalopathies, encephalopathy-bovine-spongiform, fatal-familial-insomnia, gliosis, kuru, nervousness, neurodegenerative-disorders, neuropathology-disease, new-variant-creutzfeldt-jakob-disease, plaque-amyloid, prion-diseases, scrapie, sleeplessness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Gerstmann-straussler-scheinker Disease, and have been seen in publications frequently: Amyloid Fibril Formation, Autophagy, Cell Cycle, Cell Death, Circadian Rhythm, Cognition, Glycosylation, Immune Response, Inflammatory Response, Innate Immune Response, Localization, Pathogenesis, Phagocytosis, Programmed Cell Death, Proteolysis, Reflex, Response To Nutrient, Transport, Tropism, Virulence

Quite a number of genes have been found to play important roles in Gerstmann-straussler-scheinker Disease, such as A4GALT, ABCB6, APP, ATP6V0A4, C4BPA, CARD14, CSF2, GSS, KCNE1, LAMC2, MAPT, MINK1, PLP2, PRDX2, PRNP, SGCG, TG, YWHAQ. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.